Main > > >CERVICAL CANCER. *

Diag.: BioPhotonics Scanning Device.
EU Approval Date: 2020. 07.01.
IN Approval Date: 2018. 03.12.
MX Approval Date: 2014. 07.10.
(*) Company; Patents; TradeMark & Web-
Site Available on Request.
UpDate: 2020. 09.26.




Diag.: Cell Detection. Staining.
Approved in CN; EU & IL.
(*) Company; Patents; TradeMark & Web-
Site Available on Request.
UpDate: 2018. 06.18.





Diag.: Mobile Colpocope.
Enhanced Visual Assessment
Internet Connected Colposcope
Mobile Phone Devices ..
USA Approval Date: 2016. 12.19.
(*) Company : MobileODT Ltd.
TradeMark: EVA System
Web-Site :
www.mobileodt.com/eva-system/
UpDate: 2018. 06.18.




Prevention. HPV Bivalent (Types 16 & 18) Vaccine, ReCombinant.
USA Initial Approval: 2009.
(*) Company; Patents; TradeMark & Web-
Site Available on Request.
UpDate: 2018. 06.18.




Prevention. HPV 9-Valent Vaccine ReCombinant.
USA Approval Date: ?
(*) Company; Patents; TradeMark & Web-
Site Available on Request.
UpDate: 2018. 06.18.




Treat.: BevacizuMAb. BioSimilar.
USA Approval Date: 2017. 09.14.
USA Launch Date: 2019. 07.18.
(*) Company : Amgen.
TradeMark: MVASI.
UpDate: 2019. 11.12.




Treat.: BevacizuMAb. BioSimilar.
EU Approval Date : 2019. 02.19.
USA Approval Date: 2019. 06.28.
(*) Company : Pfizer.
TradeMark: ZIRABEV.
UpDate: 2020. 01.08.




Treat.: BrachyTherapy.
Cervix
parametrium and vaginal extensions
stage IIIA, IIIB and IVA tumors
EU Approval Date : 2016. 11.
USA 510(k) Clearance: 2017. 02.02.
(*) Company : Elekta AB.
TradeMark: Venezia.




Treat.: BrachyTherapy. Vaginal>
>Balloon Packing System
>Reduction in Bladder & Rectal Dose
USA>FDA>Cleared
(*) Company; Patents; TradeMark & Web-
Site Available on Request.
UpDate: 2018. 06.18.




Treat.: BrachyTherapy. X-Ray.
EU Approval Date : 2015. 07.13.
USA Approval Date: 2013. 03.20.
USA Launch Date : 2015. 07.13.
(*) Company : iCAD Inc.
TradeMark: Xoft Axxent eBx System
Web-Site : www.xoftinc.com/
UpDate: 2018. 06.18.




Treat.: CO2 Based CryoTherapy Device
IN Launch Date: 2021. 01.14.
(*) Company; Patent; Product Name & Web-
Site Available on Request.
UpDate: 2021. 02.22.




Treat.: PembrolizuMAb Inj.
(METASTATIC>RECURRENT)
USA Approval Date: ?
(*) Company; Patents; TradeMark & Web-
Site Available on Request.
UpDate: 2020. 01.01.




Treat.: TopoTecan for Inj.+CisPlatin
USA Initial Approval: 1996.
(*) Company : GlaxoSmithKline.
Dist. USA: Novartis
Patent : Expired in 2010. 05.28.
TradeMark: Hycamtin


>CERVICAL CANCER. *'s products
This section has no products